Hear from the experts, watch the videos from the 2023 Know All Your Treatment Options and Caregiver events.

People diagnosed with certain Metastatic Cancers are invited to participate in a paid online survey of treatment and management of these cancers.

The FDA expanded use of Temodar to include two new indications for the treatment of adults with anaplastic astrocytoma.

Get ready to celebrate Giving Tuesday on November 28th, 2023 by supporting EBCI's services and programs.

Shreya Prakash will work with GBM patients to coordinate clinical trials and to provide information on treatments, drugs, and specialists.

Jenn Ortiz, a two-time brain tumor survivor, describes her participation in the Patient Reported Outcomes rGBM study.

Gleolan Brain Dye, imaging agent, helps neurosurgeons to see “high grade gliomas” during surgery. Learn about Gleolan.

Northwest Biotherapeutics has applied for approval to market DCVax®, a personalized immune therapy, for the treatment of Glioblastoma.

People diagnosed with certain Metastatic Cancers are invited to participate in a paid online survey of treatment and management of these cancers.

We are looking for Glioblastoma (GBM) patients and their caregivers to participate in an important study on recurrent GBM.

PROSPECT is an open-label, Phase II study evaluating the efficacy, safety, and pharmacokinetics of an oral medicine called Tirabrutinib.

People living with glioblastoma multiforme (GBM) are invited to participate in this online survey about their experience.